Purchase Order HHSN272201800528P

This federal contract award was made by the Environmental Protection Agency's (EPA) Office of Research and Development to Trilink Biotechnologies, LLC, a for-profit limited liability company based in San Diego, California. The $149,999.87 firm fixed-price purchase order is for custom messenger RNA (mRNA) synthesis services, with a completion date of September 26, 2025. The contract was awarded on April 22, 2025 and does not have a set-aside designation, indicating Trilink Biotechnologies was...

The Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $148,000.00 contract is for the delivery of SuperScript III Reverse Transcriptase, with a performance period of 30 days. This open-market commercial item award was made under a combined...

Genscript USA Incorporated will provide gene synthesis services to the National Institutes of Health's National Institute of Allergy and Infectious Diseases under a $12,500 firm fixed price purchase order. The one-year contract was awarded on September 14, 2023 and runs through September 13, 2024. Genscript will deliver the gene synthesis work from its location in Piscataway, New Jersey. No subcontractors or additional context were provided regarding the specific research being supported under...

This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The $22,179 contract is for gene synthesis and cloning services to support ongoing research on respiratory syncytial virus (RSV)-associated illness and pneumonia. This work involves analyzing precious clinical samples already in progress. The contract...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $21,095.60 contract is for the provision of custom gene synthesis services to support NIAID's biomedical research and public health initiatives. Genscript USA Inc. is an experienced federal contractor, having received numerous...

This is a $9,624.25 purchase order contract awarded by the National Institutes of Health (NIH) to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the procurement of Superscript III Reverse Transcriptase, which is a proprietary mutant version of Superscript II RT that is active at 50°C. This contract does not have a set-aside designation. As a prime contractor to the NIH, Life Technologies has also supported...

This federal contract award is for the procurement of 10 units of SUPERSCRIPT III REVERSE TRANSCRIPTASE, CAT# 18080-085, at a unit price of $891.20, for a total ceiling value of $15,683.98. The contracting agency is the National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services (HHS). The contract was awarded to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, as the prime contractor. This contract is a Blanket Purchase...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...

This federal contract award involves the procurement of a SUPERSCRIPT VILO CDNA SYNTHESIS KIT 250RXN from Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract has a ceiling value of $1,840.30 and is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. The award supports NIAID's biomedical research initiatives, providing the specialized reagents and consumables required...

This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...